Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "RIL"

1504 News Found

AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes
Healthcare | April 06, 2026

AstraZeneca, Roche-backed study supports risk-based HF screening in diabetes

Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care


Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management
People | April 06, 2026

Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management

In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio


Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
Appointment | April 05, 2026

Sun Pharma appoints former PwC India COO Satyavati Berera as independent director

Board approves five-year appointment, subject to shareholder nod through postal ballot


Max Healthcare allots 57,461 equity shares under ESOP 2022
Hospitals | April 05, 2026

Max Healthcare allots 57,461 equity shares under ESOP 2022

Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees


KIMS enters Kerala with 20-year operations pact for Avitis Super Speciality Hospital in Palakkad
Hospitals | April 05, 2026

KIMS enters Kerala with 20-year operations pact for Avitis Super Speciality Hospital in Palakkad

Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later


Senores makes bold US push with new federal-focused JV
News | April 05, 2026

Senores makes bold US push with new federal-focused JV

Company leadership is framing the move as transformational.


Kauvery Hospital sets new benchmark in high-risk cardiac care
Hospitals | April 04, 2026

Kauvery Hospital sets new benchmark in high-risk cardiac care

71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day


Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
Biotech | April 04, 2026

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy


PHARMEXCIL Chintan Shivir in Hyderabad charts roadmap to scale India’s pharma exports
News | April 04, 2026

PHARMEXCIL Chintan Shivir in Hyderabad charts roadmap to scale India’s pharma exports

Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26